Form 4: Sutro Biopharma Executive Venkatesh Srinivasan Reports Stock Transactions
SEC Form 4 Filing
Venkatesh Srinivasan, Chief Technical Operations Officer of Sutro Biopharma, reports the acquisition and disposal of common stock and restricted stock units on May 1, 2025.
Summary
- On May 1, 2025, Venkatesh Srinivasan, Chief Technical Operations Officer of Sutro Biopharma, engaged in transactions involving the company's stock.
- Srinivasan acquired 2,500 shares of common stock through the vesting of restricted stock units (RSUs).
- 894 shares were withheld by the issuer to cover income tax obligations related to the RSU settlement, not representing a sale by Srinivasan.
- Following these transactions, Srinivasan directly owns 53,686 shares of Sutro Biopharma common stock and 5,000 RSUs.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company executives as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | RSUs vest as to 1/4th of the total award annually beginning on this date, subject to continued service through each vesting date. |
| 05/01/2025 | Date of the reported transactions: acquisition of common stock and RSUs. |
| 05/01/2027 | Expiration date of the Restricted Stock Units. |
| 05/05/2025 | Date of signature on the Form 4 filing. |
Keywords
Sutro Biopharma, Venkatesh Srinivasan, Form 4, Stock Transactions, Restricted Stock Units, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.